Print

Disclosure of Interests - Mark Bloch

Year*Type of relationshipEntityCommentPayment received
Board membership ViiV Healthcare; Gilead Sciences; Janssen; Boehringer-Ingelheim; Eli Lilly Yes
Consultancy MSD  HIV consultancy Yes
Grants / grants pending ViiV Healthcare; Abbvie; MSD; Janssen; Bristol Myers-Squibb Yes - Institution only
Payment for development of educational presentations including service on speaker' bureaus Eli Lilly Men's Health Yes
Payment for development of educational presentations including service on speaker' bureaus ViiV Healthcare HIV presentations Yes
Travel / accommodation expenses covered or reimbursed ViiV Healthcare; Gilead Sciences; MSD; Boehringer-Ingelheim; Bristol Myers-Squibb; Eli Lilly Travel to scientific meetings Yes


* Information provided for period of 36 months preceding 01 May 2013

This year's virtual 2020 Joint Australasian HIV&AIDS and Sexual Health Conferences were an amazing success. Thank y… https://t.co/H7WOZAsK2z

ASHM ASHM

The National Hepatitis C Testing Policy has been updated. This policy brings together in one place the principles,… https://t.co/Tad4vYMy89

ASHM ASHM